Roche's Accu-Chek diabetes care medical devices, used by millions of patients, include Accu-Chek glucometers, blood glucose ...

The U.S.'s drug regulator has approved Roche's Susvimo drug for the treatment of diabetic macular edema, the leading cause of diabetes-related blindness, the pharmaceutical company said.

mySugr was founded in 2012 to provide an all-round care service for people with diabetes, combining coaching, therapy management, test strips and data tracking. Roche had been partnering with ...

Roche’s diabetes arm is working with Ieso Digital Health to test the Cambridge, UK-based digital therapeutics firm’s mental health programme in type 2 diabetes patients in the UK and Ireland.

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.